Trinity Legacy Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Trinity Legacy Partners's PFE Position: Q3 2023 in Review
Trinity Legacy Partners sold out of Pfizer (PFE) in Q3 2023, closing a stake of 6,866 shares — an estimated $252K sold.
Trinity Legacy Partners first reported a position in PFE in Q4 2019 and held it in 14 quarters. The position peaked at $5.76M in Q4 2021. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.
- Trinity Legacy Partners reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
- Trinity Legacy Partners sold 6,866 Pfizer shares in Q3 2023, an estimated $252K.
- Trinity Legacy Partners first reported a position in Pfizer in Q4 2019 and held it in 14 quarters.
- Trinity Legacy Partners's Pfizer position peaked at $5.76M in Q4 2021.
- 2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.
Based on Trinity Legacy Partners's 13F filing for Q3 2023, filed 11 Oct 2023.